BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeh SJ, Lin CY, Li CW, Chen BS. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer. Int J Mol Sci 2019;20:E2536. [PMID: 31126066 DOI: 10.3390/ijms20102536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Subhi O, Schulten HJ, Bagatian N, Al-Dayini R, Karim S, Bakhashab S, Alotibi R, Al-Ahmadi A, Ata M, Elaimi A, Al-Muhayawi S, Mansouri M, Al-Ghamdi K, Hamour OA, Jamal A, Al-Maghrabi J, Al-Qahtani MH. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis. PLoS One 2020;15:e0234566. [PMID: 32603365 DOI: 10.1371/journal.pone.0234566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN. Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals (Basel) 2021;14:369. [PMID: 33923474 DOI: 10.3390/ph14040369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gulfidan G, Soylu M, Demirel D, Erdonmez HBC, Beklen H, Ozbek Sarica P, Arga KY, Turanli B. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks. Arch Biochem Biophys 2022;715:109085. [PMID: 34800440 DOI: 10.1016/j.abb.2021.109085] [Reference Citation Analysis]
4 Wang XR, Cao TT, Jia CM, Tian XM, Wang Y. Quantitative prediction model for affinity of drug-target interactions based on molecular vibrations and overall system of ligand-receptor. BMC Bioinformatics 2021;22:497. [PMID: 34649499 DOI: 10.1186/s12859-021-04389-w] [Reference Citation Analysis]